KLK13 Antibodies

Santa Cruz Biotechnology provides a broad selection of KLK13 monoclonal antibodies for research focused on understanding KLK13 protein function. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KLK13, also known as kallikrein-related peptidase 13, is a serine protease that plays a significant role in various physiological processes, including skin desquamation and the regulation of inflammation. KLK13 dysregulation has been implicated in several diseases, particularly in cancer development and progression. Research has shown that KLK13 expression levels can vary significantly between normal and cancerous tissues, suggesting its potential as a diagnostic marker. Understanding KLK13 function and regulation is crucial for developing new therapeutic strategies. Investigating KLK13's role in different cellular pathways can reveal new insights into disease mechanisms. Current research indicates that KLK13 may interact with multiple substrates, affecting various signaling cascades. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of KLK13's role in health and disease.